(Health-NewsWire.Net, April 23, 2016 ) The Chronic Obstructive Pulmonary Disease Industry Report shows that persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity and the fifth-leading cause of death in the world. COPD is linked to cumulative exposure to risk factors, primarily tobacco smoke, but also environmental pollutants. The COPD marketed products landscape consists of pharmacological therapies aimed at managing the symptoms associated with COPD, although none of the available therapies have been shown to modify long-term disease progression. The current COPD pipeline consists of 212 active products in development. Initial analysis revealed a small presence of first-in-class products, constituting 16.5% of the pipeline. In comparison to other indications, this is relatively low; however, there are some promising trends within COPD product development.
Other Key Points in Report:
The COPD market has benefited from notable additions in recent years. -Which classes of drug dominate the market? -What additional benefits have newly approved therapies brought to market? -How do the leading marketed therapies compare clinically? The pipeline contains a range of molecule types and molecular targets, including those that are well established in COPD and novel, first-in-class therapies. -Which molecular targets appear most frequently in the pipeline? -To what degree is the pipeline penetrated by first-in-class innovation? -Which target families consist of the most first-in-class products? First-in-class products differ substantially in their clinical potential, based on their alignment to disease causing pathways. -How well are first-in-class targets aligned to known disease causing pathways? -Which targets are specifically found in early-stage development? -What is the industry-wide interest in these targets? -Which are the most promising first-in-class targets in early-stage development?
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.